Effect of rescue medication on seizure duration in non-institutionalized children with epilepsy

Federico Vigevano1, Fenella J Kirkham2, Bernd Wilken3

  • 1Department of Neuroscience, Bambino Gesù Children's Hospital, Rome, Italy.

Insights

Community-administered rescue medications significantly shorten prolonged acute convulsive seizures (PACS) in children with epilepsy. This real-world study confirms their effectiveness in reducing seizure duration when given promptly.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Management
  • Pharmacology

Background:

  • Prolonged acute convulsive seizures (PACS) in children with epilepsy require prompt intervention.
  • Rescue medications are crucial for managing these events in community settings.
  • Understanding real-world usage and outcomes is essential for optimizing care.

Purpose of the Study:

  • To characterize the real-world management of children with epilepsy experiencing PACS.
  • To evaluate the outcomes of using rescue medications in the community for PACS.
  • To assess the timeliness of rescue medication administration.

Main Methods:

  • A European, retrospective observational study (PERFECT-3) involving 286 children (3-16 years) with epilepsy and a history of PACS.
  • Data collected via investigator clinical assessments and parent/guardian questionnaires.
  • Analysis focused on rescue medication prescriptions, seizure duration, and administration timing.

Main Results:

  • Most children were prescribed diazepam and/or midazolam; 26.6% had multiple rescue medications.
  • Rescue medication use was significantly associated with shorter seizure durations (<5 minutes).
  • A high percentage of children received rescue medication within 5-10 minutes of seizure onset.

Conclusions:

  • Community-administered rescue medications effectively reduce the duration of PACS in children with epilepsy.
  • This study provides the first real-world evidence supporting the efficacy of these interventions.
  • Acknowledged limitations include potential recall bias, underscoring the need for further research.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
843
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
24
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
335
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
269